|
1
|
Jemal A, Ward E and Thun MJ: Recent trends
in breast cancer incidence rates by age and tumor characteristics
among U.S. women. Breast Cancer Res. 9:R282007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang S, Lee JM, Lee JK, Kim JW, Cho CH,
Kim SM, Park SY, Park CY and Kim KT: How low is low enough?
Evaluation of various risk-assessment models for lymph node
metastasis in endometrial cancer: A Korean multicenter study. J
Gynecol Oncol. 23:251–256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pecorelli S, Pasinetti B, Angioli R,
Favalli G and Odicino F: Systemic therapy for gynecological
neoplasms: Ovary, cervix, and endometrium. Cancer Chemother Biol
Response Modif. 22:515–544. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiemer EA and Berns EM: MicroRNA
regulation of RAD51 in serous ovarian cancer modulates chemotherapy
response. J Natl Cancer Inst. 107:2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Yan Q, Li S, Zhou L, Yang H, Yang
Y, Liu X and Wan X: Expression of the tumor suppressor miR-206 is
associated with cellular proliferative inhibition and impairs
invasion in ERα-positive endometrioid adenocarcinoma. Cancer Lett.
314:41–53. 2012. View Article : Google Scholar
|
|
6
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rajewsky N and Socci ND: Computational
identification of microRNA targets. Dev Biol. 267:529–535. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X: A microRNA as a translational
repressor of APETALA2 in Arabidopsis flower development. Science.
303:2022–2025. 2004. View Article : Google Scholar
|
|
9
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
11
|
Garzon R, Fabbri M, Cimmino A, Calin GA
and Croce CM: MicroRNA expression and function in cancer. Trends
Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee TS, Jeon HW, Kim YB, Kim YA, Kim MA
and Kang SB: Aberrant microRNA expression in endometrial carcinoma
using formalin-fixed paraffin-embedded (FFPE) tissues. PLoS One.
8:e814212013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
15
|
Hobert O: Gene regulation by transcription
factors and microRNAs. Science. 319:1785–1786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bandyopadhyay S, Mitra R, Maulik U and
Zhang MQ: Development of the human cancer microRNA network.
Silence. 1:62010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Plummer PN, Freeman R, Taft RJ, Vider J,
Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al:
MicroRNAs regulate tumor angiogenesis modulated by endothelial
progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar
|
|
20
|
Palmieri A, Pezzetti F, Brunelli G,
Martinelli M, Scapoli L, Arlotti M, Masiero E and Carinci F: Medpor
regulates osteoblast's microRNAs. Biomed Mater Eng. 18:91–97.
2008.PubMed/NCBI
|
|
21
|
Palmieri A, Pezzetti F, Spinelli G,
Arlotti M, Avantaggiato A, Scarano A, Scapoli L, Zollino I and
Carinci F: PerioGlas regulates osteoblast RNA interfering. J
Prosthodont. 17:522–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Annalisa P, Furio P, Ilaria Z, Anna A,
Luca S, Marcella M, Marzia A, Elena M and Carinci F: Anorganic
bovine bone and a silicate-based synthetic bone activate different
microRNAs. J Oral Sci. 50:301–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhang M, Chen H, Dong Z, Ganapathy
V, Thangaraju M and Huang S: Ratio of miR-196s to HOXC8 messenger
RNA correlates with breast cancer cell migration and metastasis.
Cancer Res. 70:7894–7904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhong N, Sun J, Min Z, Zhao W, Zhang R,
Wang W, Tian J, Tian L, Ma J, Li D, et al: MicroRNA-337 is
associated with chondrogenesis through regulating TGFBR2
expression. Osteoarthritis Cartilage. 20:593–602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang R, Zheng S, Du Y, Wang Y, Zang W and
Zhao G: Levels of HOXB7 and miR-337 in pancreatic ductal
adenocarcinoma patients. Diagn Pathol. 9:612014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Wang J, Yang Y, Hao B, Wang R, Li
Y and Wu Q: Loss of has-miR-337-3p expression is associated with
lymph node metastasis of human gastric cancer. J Exp Clin Cancer
Res. 32:762013. View Article : Google Scholar :
|
|
27
|
Song MS, Salmena L and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor. Nat Rev Mol
Cell Biol. 13:283–296. 2012.PubMed/NCBI
|
|
28
|
Blanco-Aparicio C, Renner O, Leal JF and
Carnero A: PTEN, more than the AKT pathway. Carcinogenesis.
28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu M and Mo YY: The Akt-associated
microRNAs. Cell Mol Life Sci. 69:3601–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang D, Wang TY, Li HC, Wei JC and Song
JX: Prognostic significance of PTEN expression in esophageal
squamous cell carcinoma from Linzhou City, a high incidence area of
northern China. Dis Esophagus. 20:491–496. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tachibana M, Shibakita M, Ohno S, Kinugasa
S, Yoshimura H, Ueda S, Fujii T, Rahman MA, Dhar DK and Nagasue N:
Expression and prognostic significance of PTEN product protein in
patients with esophageal squamous cell carcinoma. Cancer.
94:1955–1960. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou YA, Zhang T, Zhao JB, Wang XP, Jiang
T, Gu ZP, Wang XN and Li XF: The adenovirus-mediated transfer of
PTEN inhibits the growth of esophageal cancer cells in vitro and in
vivo. Biosci Biotechnol Biochem. 74:736–740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding Y, Shimada Y, Kano M, Itami A, Kawabe
A, Maeda M, Li Z, Hong T, Sato F, Kaganoi J and Imamura M:
PTEN/MMAC1 expression in esophageal squamous cell carcinomas. Int J
Oncol. 17:695–699. 2000.PubMed/NCBI
|
|
34
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bar N and Dikstein R: miR-22 forms a
regulatory loop in PTEN/AKT pathway and modulates signaling
kinetics. PLoS One. 5:e108592010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Garofalo M, Di Leva G, Romano G, Nuovo G,
Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P,
et al: miR-221&222 regulate TRAIL resistance and enhance
tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell.
16:498–509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY and Fu L:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar
|
